Mirxes
Singapore · Founded 2014
About Mirxes
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $349.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: hkg:2629
- Website: mirxes.com
- Phone: 6779 7340
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mirxes-16212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.